An ACT-Based Supportive Intervention for Patients With Central Nervous System Tumors

Status: Recruiting
Location: See location...
Intervention Type: Other, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this study is to refine and test a psychosocial intervention called ASCENT (ACT-based Supportive intervention for patients with CENTral nervous system tumors). This intervention was developed to help patients after being diagnosed with a brain tumor. The main question this study aims to answer is whether this intervention is feasible (i.e., possible to carry out) and acceptable (i.e., considered helpful) to patients. Participants will be asked to take part in 6 coaching sessions and complete short surveys at four different time points. Some participants will be asked to share feedback via interviews.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥ 18

• Massachusetts General Hospital Cancer Center Patient

• Within 6 months of diagnosis of malignant primary Central Nervous System (CNS) tumor

• English speaking

Locations
United States
Massachusetts
Massachusetts General Hospital Cancer Center
RECRUITING
Boston
Contact Information
Primary
Deborah A Forst, MD
dforst@mgb.org
617-724-4000
Time Frame
Start Date: 2025-05-15
Estimated Completion Date: 2029-07-31
Participants
Target number of participants: 100
Treatments
Experimental: Pilot RCT: ASCENT Arm
Enrolled patients will receive an intervention manual and will participate in six weekly or biweekly individual sessions with a clinician (e.g. nurse or behavioral health specialist).~Participants will be asked to complete surveys at baseline, 6 weeks, 12 weeks, and 16 weeks.
Active_comparator: Pilot RCT: Control Arm
Participants will receive usual supportive care, which includes referral to cancer center supportive care services (e.g., social work) upon request from the patient, caregiver, or clinician.~Participants will be asked to complete surveys at baseline, 6 weeks, 12 weeks, and 16 weeks.
Related Therapeutic Areas
Sponsors
Leads: Massachusetts General Hospital

This content was sourced from clinicaltrials.gov